METAGENICS

Main information

  • Trade name:
  • METAGENICS RESVERATROL HEALTHY AGEING COMPLEX
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • METAGENICS RESVERATROL HEALTHY AGEING COMPLEX
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 222465
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

222465

METAGENICS RESVERATROL HEALTHY AGEING COMPLEX

ARTG entry for

Medicine Listed

Sponsor

Health World Ltd

Postal Address

PO Box 675,VIRGINIA BC, QLD, 4014

Australia

ARTG Start Date

14/04/2014

Product category

Medicine

Status

Active

Approval area

Listed Medicines

Conditions

Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be

kept.

The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.

Products

1. METAGENICS RESVERATROL HEALTHY AGEING COMPLEX

Product Type

Single Medicine Product

Effective date

14/04/2014

Warnings

If symptoms persist consult your healthcare practitioner (or words to that effect).

Standard Indications

May assist in the maintenance of normal healthy blood sugar/glucose levels in healthy individuals.

Specific Indications

Polygonum has been used to support healthy immune function in Traditional Chinese Medicine.

Polygonum has been used to support normal healthy blood glucose levels in normal healthy people in Traditional Chinese Medicine.

Polygonum has been used to support healthy blood circulation in Traditional Chinese Medicine.

Quercetin may play a role in supporting healthy cardiovascular function in the elderly through its action as an antioxidant.

Polygonum and Quercetin may support a healthy cardiovascular system, healthy immune function and normal blood sugar levels in normal healthy

individuals as part of healthy ageing.

Resveratrol, turmeric and quercetin are antioxidants and may help defend against free radical damage.

Resveratrol Healthy Ageing Complex may help to protect cellular DNA against free radical damage.

Resveratrol Healthy Ageing Complex provides 300 mg per day of the antioxidant resveratrol and an exclusive enhanced bioavailability BCM turmeric

extract.

To support healthy ageing.

Resveratrol Healthy Ageing Complex may support the healthy ageing of cardiovascular and immune function. Resveratrol Healthy Ageing Complex may

also support normal blood sugar levels in normal healthy individuals as a part of healthy ageing. Quercetin is an antioxidant that may help to assist

healthy cardiovascular function in an older population. Resveratrol Healthy Ageing Complex provides 300 mg per day of the antioxidant, resveratrol and

an exclusive enhanced bioavailability BCM-95 turmeric extract.

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule

Components

1. Formulation 1

Dosage Form

Tablet, film coated

Public Summary

Page 1 of

Produced at 26.11.2017 at 11:19:04 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Route of Administration

Oral

Visual Identification

Active Ingredients

Curcuma longa

152 mg

Equivalent: Curcuma longa (Dry)

3.8 g

Quercetin

200 mg

Reynoutria japonica

600 mg

Equivalent: Reynoutria japonica (Dry)

60 g

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 26.11.2017 at 11:19:04 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information